arabinofuranosyluracil has been researched along with Lactic Acidosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fung, J; Lai, CL; Seto, WK; Yuen, MF | 1 |
Conjeevaram, H; Di Bisceglie, AM; Fried, MW; Kleiner, D; Luciano, C; McKenzie, R; Park, Y; Sallie, R; Savarese, B; Tsokos, M | 1 |
Brahams, D | 1 |
Miller, JP; Mintz, PD | 1 |
1 review(s) available for arabinofuranosyluracil and Lactic Acidosis
Article | Year |
---|---|
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
Topics: Acidosis, Lactic; Adenine; Administration, Oral; Antiviral Agents; Arabinofuranosyluracil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Organophosphonates; Pharmacovigilance; Pregnancy; Telbivudine; Tenofovir; Thymidine | 2014 |
2 trial(s) available for arabinofuranosyluracil and Lactic Acidosis
Article | Year |
---|---|
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; DNA, Viral; Drugs, Investigational; Female; Hepatitis B; Humans; Jaundice; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases | 1995 |
Deaths in US fialuridine trial.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Survival Rate | 1994 |
1 other study(ies) available for arabinofuranosyluracil and Lactic Acidosis
Article | Year |
---|---|
Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
Topics: Acidosis, Lactic; Anticoagulants; Antiviral Agents; Arabinofuranosyluracil; Calcium; Citrates; Citric Acid; Hepatitis B; Hepatorenal Syndrome; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Plasma Exchange; Predictive Value of Tests; Spectrophotometry, Atomic | 1994 |